Study Investigating Anti-drug Antibodies in NSCLC Patients Exposed to Checkpoint Inhibitors (IMB)

NCT06823401 · clinicaltrials.gov ↗
RECRUITING
Status
270
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Fondazione Ricerca Traslazionale